Eden Research focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health, and consumer products industries, has announced that it has passed a key milestone in the US for the approval of its products, Mevalone and Cedroz. In addition, Eden’s biofungicide, Mevalone, has received authorization for use on new crops in Italy for the control of the disease Botrytis cinerea, a destructive fungal pathogen affecting many plant species as well as authorization for use against additional fungal pathogens Powdery Mildew and Sclerotinia.
The United States Environmental Protection Agency (EPA) has confirmed that it has granted Eden’s plastic-free, microencapsulation technology, Sustaine®, an exemption from the requirement of a tolerance for residues in pesticide formulations in pre-harvest applications to crops. This is a key milestone with Eden now in the final stages of a process, which should result in its three active ingredients (eugenol, geraniol, and thymol) and two formulated products (Mevalone and Cedroz) receiving authorization in the US in 2022.
The addressable markets in the US, based on the products’ current labels, are approximately €94m for Mevalone and €189m for Cedroz. With the demand for biopesticides such as these increasing significantly in the US due to rising regulatory restrictions for conventional chemicals, the tolerance exemption and subsequent approvals will present a significant opportunity for Eden.
Read the complete article at www.directorstalkinterviews.com.